Edwards Lifesciences Valuation
| EW Stock | USD 86.65 0.59 0.68% |
At this time, the firm appears to be undervalued. Edwards Lifesciences Corp shows a prevailing Real Value of $101.06 per share. The current price of the firm is $86.65. Our model computes the value of Edwards Lifesciences Corp from reviewing the firm fundamentals such as Profit Margin of 0.23 %, current valuation of 52.76 B, and Shares Outstanding of 601.93 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise buying undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Edwards Lifesciences' valuation include:
Price Book 8.1717 | Enterprise Value 52.8 B | Enterprise Value Ebitda 30.3262 | Price Sales 9.0498 | Forward PE 32.8947 |
Undervalued
Today
Please note that Edwards Lifesciences' price fluctuation is very steady at this time. Calculation of the real value of Edwards Lifesciences Corp is based on 3 months time horizon. Increasing Edwards Lifesciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Edwards Lifesciences Corp is useful when determining the fair value of the Edwards stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Edwards Lifesciences. Since Edwards Lifesciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Edwards Stock. However, Edwards Lifesciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 86.65 | Real 101.06 | Target 91.33 | Hype 87.24 | Naive 85.67 |
The real value of Edwards Stock, also known as its intrinsic value, is the underlying worth of Edwards Lifesciences Corp Company, which is reflected in its stock price. It is based on Edwards Lifesciences' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Edwards Lifesciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Edwards Lifesciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Edwards Lifesciences Corp helps investors to forecast how Edwards stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Edwards Lifesciences more accurately as focusing exclusively on Edwards Lifesciences' fundamentals will not take into account other important factors: Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Edwards Lifesciences' intrinsic value based on its ongoing forecasts of Edwards Lifesciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Edwards Lifesciences' closest peers. When choosing an evaluation method for Edwards Lifesciences Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.
Edwards Lifesciences Investments |
|
Edwards Valuation Trend
Knowing Edwards Lifesciences' actual value is paramount for traders to make sound investment determinations. Edwards Lifesciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Edwards Lifesciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Edwards Lifesciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.
Edwards Market Cap
Edwards Lifesciences Corp is rated # 5 in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 692.52 Billion. Edwards Lifesciences holds roughly 54.2 Billion in market capitalization claiming about 8% of equities under Health Care industry.Edwards Lifesciences Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.Edwards Lifesciences Corp is rated below average in price to earning category among related companies. It is rated # 3 in price to book category among related companies fabricating about 0.25 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Edwards Lifesciences Corp is roughly 4.01 . Price To Book Ratio is likely to drop to 4.82 in 2024. Comparative valuation analysis is a catch-all model that can be used if you cannot value Edwards Lifesciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Edwards Lifesciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Edwards Lifesciences' earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Edwards Lifesciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Edwards Lifesciences and how it compares across the competition.
About Edwards Lifesciences Valuation
The stock valuation mechanism determines the current worth of Edwards Lifesciences Corp on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Edwards Lifesciences Corp. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Edwards Lifesciences Corp based exclusively on its fundamental and basic technical indicators. By analyzing Edwards Lifesciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Edwards Lifesciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Edwards Lifesciences. We calculate exposure to Edwards Lifesciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Edwards Lifesciences's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.6 B | 4.9 B | |
| Pretax Profit Margin | 0.27 | 0.14 | |
| Operating Profit Margin | 0.26 | 0.16 | |
| Net Profit Margin | 0.23 | 0.25 | |
| Gross Profit Margin | 0.77 | 0.54 |
Edwards Lifesciences Quarterly Retained Earnings |
|
8 Steps to conduct Edwards Lifesciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Edwards Lifesciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Edwards Lifesciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Edwards Lifesciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Edwards Lifesciences' revenue streams: Identify Edwards Lifesciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Edwards Lifesciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Edwards Lifesciences' growth potential: Evaluate Edwards Lifesciences' management, business model, and growth potential.
- Determine Edwards Lifesciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Edwards Lifesciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Edwards Lifesciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Edwards Lifesciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 609.4 M | |
| Quarterly Earnings Growth Y O Y | -0.061 | |
| Forward Price Earnings | 32.8947 |
Edwards Lifesciences Current Valuation Indicators
Valuation refers to the process of determining the present value of Edwards Lifesciences Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Edwards we look at many different elements of the entity such as Edwards's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Edwards Lifesciences' valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Edwards Lifesciences' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Edwards Lifesciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Edwards Lifesciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Edwards Lifesciences' worth.When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.